News | June 13, 2026
Novo Nordisk confirms cyber breach after hackers access personal data
Despite the disruption, the company stressed that “our core business operations are not impacted and remain up and running.
Despite the disruption, the company stressed that “our core business operations are not impacted and remain up and running.
Approval is based on results from the phase 3 OASIS 4 clinical trial
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi
Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance
Recognition highlights the hospital network’s decade-long investment in analytics and AI-driven healthcare, supporting improved outcomes, efficiency, and affordability.
Developed by the Sudha Gopalakrishnan Brain Centre, the publicly accessible ANCHOR atlas maps over 200 brainstem structures at cellular resolution, offering new possibilities for neuroscience research and clinical applications
Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery
Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer
The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
Subscribe To Our Newsletter & Stay Updated
